Sparta Biomedical Receives FDA Breakthrough Device Designation for SBM-01 Biomimetic Implant

Sparta Biomedical was granted FDA's Breakthrough Device Designation. SBM-01 is intended to replace damaged knee cartilage in patients having single or multiple chondral or osteochondral defects in the knee.

SBM-01 mimics the properties of native cartilage and provides a smooth articulating surface, offering support to surrounding cartilage...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0